Breaking News Instant updates and real-time market news.

ZUO

Zuora

$19.87

-0.46 (-2.26%)

05:04
05/31/19
05/31
05:04
05/31/19
05:04

Zuora price target lowered to $29 from $35 at Jefferies

Jefferies analyst John DiFucci lowered his price target for Zuora to $29 from $35 saying the company's fiscal Q1 results were "mixed." The analyst says that while guidance for Q2 was below consensus estimates and reduced for the year, he views this as "prudent." DiFucci continues to believe that Zuora will grow at a rate of at least 25%-30% over the next 5-10 years and he keeps a Buy rating on the shares.

  • 10

    Jun

  • 18

    Jun

ZUO Zuora
$19.87

-0.46 (-2.26%)

03/20/19
NEED
03/20/19
NO CHANGE
Target $30
NEED
Strong Buy
Zuora price target raised to $30 from $27 at Needham
Needham analyst Scott Berg raised his price target on Zuora to $30 and kept his Strong Buy rating ahead of its Q4 results, saying his forecasts suggest that earnings will top expectations. The analyst cites strengthening in the company's technology and media verticals and anticipates that the company to "sustain the high 20% to 30% growth profile for several years". Berg also expects Zuora to reduce its free cash flow burn by about $10M per year.
03/22/19
JEFF
03/22/19
NO CHANGE
Target $35
JEFF
Buy
Zuora business metrics strong, growth sustainable, says Jefferies
Zuora exceeded fiscal Q4 sales and met profit expectations, with similar characteristics for its Q1 guidance, "though prudent annual subscription guidance was a touch shy," Jefferies analyst John DiFucci tells investors in a research note. Zuora's business metrics were strong, and while subscription growth of 35% decelerated modestly it was against the most difficult comp this year, the analyst adds. He continues to believe the "subscription economy" will drive a growth rate of at least 25%-30% over the next five-to-ten years for Zuora. DiFucci keeps a Buy rating on the shares with a $35 price target
03/22/19
ADAM
03/22/19
NO CHANGE
Target $28
ADAM
Buy
Zuora pullback a buying opportunity, says Canaccord
Canaccord analyst Richard Davis said "there was absolutely nothing" he heard on Zuora's earnings call or his call back with management that shakes his confidence in his Buy recommendation and he suggests investors use the post-earnings pullback to fill out positions. Commentary on the call about large deal growth, transaction volumes on platform and net dollar retention were all positive, noted Davis, who continues to believe Zuora is capable of growing faster for longer than some investors expect. He maintains a Buy rating and $28 price target on Zuora shares.
04/17/19
JEFF
04/17/19
NO CHANGE
Target $35
JEFF
Buy
Zuora should grow at least 25%-30% annually for years, says Jefferies
After updating his model to reflect the ASC 606 standard, Jefferies analyst John DiFucci continues to believe that Zuora will grow at a rate of "at least" 25%-30% annually over the next five-to-ten years on the back of the subscription economy. He notes that the company expects to see an immaterial negative adjustment to its subscription revenues under ASC 606. The analyst keeps a Buy rating on the shares with a $35 price target.

TODAY'S FREE FLY STORIES

AGN

Allergan

$130.97

0.13 (0.10%)

07:30
06/24/19
06/24
07:30
06/24/19
07:30
Hot Stocks
Allergan receives FDA clearance for CoolTone device »

Allergan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPX

Tempur Sealy

$74.38

0.95 (1.29%)

, BIG

Big Lots

$28.98

-0.375 (-1.28%)

07:30
06/24/19
06/24
07:30
06/24/19
07:30
Upgrade
Tempur Sealy, Big Lots rating change  »

Tempur Sealy upgraded to…

TPX

Tempur Sealy

$74.38

0.95 (1.29%)

BIG

Big Lots

$28.98

-0.375 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOP

GasLog Partners

$21.49

0.09 (0.42%)

, GLOG

GasLog

$13.36

-0.02 (-0.15%)

07:30
06/24/19
06/24
07:30
06/24/19
07:30
Hot Stocks
GasLog, GasLog Partners agree to eliminate incentive distribution rights »

GasLog (GLOG) and GasLog…

GLOP

GasLog Partners

$21.49

0.09 (0.42%)

GLOG

GasLog

$13.36

-0.02 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
06/24/19
06/24
07:30
06/24/19
07:30
General news
Treasury Market Outlook: bonds have caught a bid »

Treasury Market Outlook:…

TRLFF

True Leaf Medicine

$0.00

(0.00%)

, NXTTF

Namaste Technologies

$0.00

(0.00%)

07:27
06/24/19
06/24
07:27
06/24/19
07:27
Hot Stocks
True Leaf Medicine announces supply agreement with Namaste Technologies »

True Leaf Brands (TRLFF)…

TRLFF

True Leaf Medicine

$0.00

(0.00%)

NXTTF

Namaste Technologies

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLP

Alliance Resource Partners

$16.96

-0.12 (-0.70%)

07:27
06/24/19
06/24
07:27
06/24/19
07:27
Hot Stocks
Alliance Resource Partners to acquire $145M of Permian Basin interests »

Alliance Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNET

RigNet

$8.64

0.22 (2.61%)

, IMASY

Inmarsat

$0.00

(0.00%)

07:25
06/24/19
06/24
07:25
06/24/19
07:25
Hot Stocks
RigNet announces settlement of Inmarsat arbitration »

RigNet (RNET) announced…

RNET

RigNet

$8.64

0.22 (2.61%)

IMASY

Inmarsat

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$76.12

-0.82 (-1.07%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Upgrade
Fortinet rating change  »

Fortinet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

POST

Post Holdings

$104.28

0.075 (0.07%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Hot Stocks
Post Holdings narrows FY19 adjusted EBITDA view $1.2B-$1.22B from $1.2B-$1.24B »

Post Holdings provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUX

Immunic

$9.71

0.04 (0.41%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Hot Stocks
Immunic to present unpublished IMU-838 data at GIIDS »

Immunic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

PSTI

Pluristem

$0.57

-0.0142 (-2.43%)

07:21
06/24/19
06/24
07:21
06/24/19
07:21
Hot Stocks
Pluristem appoints Yaky Yanay as sole CEO »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$6.57

-0.19 (-2.81%)

07:20
06/24/19
06/24
07:20
06/24/19
07:20
Conference/Events
Pfenex management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 07

    Oct

INNT

Innovate Biopharmaceuticals

$1.23

-0.025 (-2.00%)

, CGIX

Cancer Genetics

$0.17

-0.0033 (-1.89%)

07:20
06/24/19
06/24
07:20
06/24/19
07:20
Hot Stocks
Innovate Biopharmaceuticals appoints ED Sitar as CFO »

Innovate…

INNT

Innovate Biopharmaceuticals

$1.23

-0.025 (-2.00%)

CGIX

Cancer Genetics

$0.17

-0.0033 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$57.07

-0.54 (-0.94%)

07:18
06/24/19
06/24
07:18
06/24/19
07:18
Conference/Events
NuVasive management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:15
06/24/19
06/24
07:15
06/24/19
07:15
General news
FX Update: The dollar has started the week on a soft footing »

FX Update: The dollar has…

DAN

Dana

$17.94

0.05 (0.28%)

07:14
06/24/19
06/24
07:14
06/24/19
07:14
Hot Stocks
Dana announces reduction of pension liabilities »

Dana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTRN

Materion

$67.06

-0.54 (-0.80%)

07:14
06/24/19
06/24
07:14
06/24/19
07:14
Conference/Events
Materion management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 25

    Sep

CGC

Canopy Growth

$40.20

-3.495 (-8.00%)

07:13
06/24/19
06/24
07:13
06/24/19
07:13
Hot Stocks
Canopy Growth adds substantial production capacity in Canada »

Canopy Growth is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$32.46

0.58 (1.82%)

07:12
06/24/19
06/24
07:12
06/24/19
07:12
Conference/Events
MPLX management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

MDR

McDermott

$8.35

0.14 (1.71%)

07:12
06/24/19
06/24
07:12
06/24/19
07:12
Hot Stocks
McDermott awarded large offshore EPCI contract from Saudi Aramco »

McDermott announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$29.98

0.2 (0.67%)

07:10
06/24/19
06/24
07:10
06/24/19
07:10
Hot Stocks
Axalta Coating announces Chairman Charlie Shaver resigns, Mark Garrett succeeds »

Axalta Coating announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORV

Correvio

$2.27

-0.13 (-5.42%)

07:09
06/24/19
06/24
07:09
06/24/19
07:09
Hot Stocks
Correvio resubmits Brinavess NDA to FDA »

Correvio announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

07:07
06/24/19
06/24
07:07
06/24/19
07:07
Hot Stocks
Bristol-Myers: CheckMate -459 study did not reach pre-specified primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 16

    Sep

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

, CELG

Celgene

$98.92

0.75 (0.76%)

07:05
06/24/19
06/24
07:05
06/24/19
07:05
Hot Stocks
Bristol-Myers plans Otezla sale to get FTC Celgene clearance »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

CELG

Celgene

$98.92

0.75 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

, CELG

Celgene

$98.92

0.75 (0.76%)

07:03
06/24/19
06/24
07:03
06/24/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Bristol-Myers, Celgene »

Bristol-Myers plans…

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

CELG

Celgene

$98.92

0.75 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.